Concept Map for COVID-19 Pneumonia

Assessment (Recognizing Cues)

Patient history in the evaluation of John Doe includes a temperature of 102°F, shortness of breath, dry cough that is not producing phlegm, and loss of taste and smell. Most important are low oxygen saturation, 88%, and worsening respiratory distress; the patient demonstrated accessory muscles and bilateral crackles on auscultation. These include the drop in the oxygen saturation level and the onset of severe dyspnea, suggestive of COVID-19 pneumonia worsening, and thus the need to administer oxygen and closely observe the patient.

Analysis (Analyzing Cues)

Consistent with Cues:

• Acute respiratory infection (COVID-19)
• Possible development of pneumonia

Supporting Condition:

• COVID-19 Pneumonia

Cause for Concern:

• Low oxygen saturation
• Worsening respiratory distress

Other Helpful Information:

• Chest X-ray results
• Blood work, including CBC, CRP, and D-dimer

Analysis (Prioritizing Hypotheses)

.

• Likely Explanations:
  • COVID-19 Pneumonia
  • Hypoxia due to viral infection
  • Exacerbation of chronic conditions (Hypertension, Diabetes)
• Most Serious Explanation:

Acute respiratory failure

• Priority Order:

1. Acute respiratory failure

2.COVID-19 Pneumonia

1. Management of chronic conditions (Hypertension, Diabetes)

Planning (Generate Solutions)

Desirable Outcomes:

• Improve oxygenation and breathing
• Manage fever and other symptoms
• Prevent complications
• Stabilize chronic conditions

Interventions:

• Administer supplemental oxygen
• Antiviral therapy (e.g., Remdesivir)
• Corticosteroids (e.g., Dexamethasone)
• Symptomatic treatment (antipyretics, hydration)
• Continuous monitoring of vital signs and oxygen levels

Avoid:

• Use of non-recommended treatments for COVID-19
• Overuse of medications that may exacerbate chronic conditions
• SMART Goals:

Specific: Improve oxygen saturation to > 92% within 24 hours

Measurable: Monitor oxygen levels every 4 hours

Attainable: Increase oxygen flow if saturation does not improve

Realistic: Combine oxygen therapy with antiviral treatment

Time-Restricted: Reassess in 24-48 hours

Implementation (Take actions)

• Administer oxygen via nasal cannula at 4 L/min (Takeshita et al., 2020).
• Start antiviral therapy, including Remdesivir 200 mg on day 1, followed by daily IV maintenance doses of 100 mg for 5–9 days (Gattinoni et al., 2021).
• Administer corticosteroids like Dexamethasone 6 mg once daily for up to 10 days, ^three intravenously (Bahsoun et al., 2023)
• Provide acetaminophen 1000 mg every 4 to 6 for fever management*
• Encourage rest and hydration

Evaluation (Evaluating Outcomes)

Improving: Increased oxygen saturation was within (95-98%), reduced fever, stabilized respiratory rate

Patient Information (SBAR, History & Physical)

Main Concept

• S (Situation): John Doe, 55-year-old male with worsening shortness of breath and fever, suspected COVID-19.
• B: Hypertension, Type 2 Diabetes, recent family gathering.
• A: Fever, cough, loss of taste/smell, lung crackles, low oxygen saturation.
• R: Initiate oxygen therapy and antiviral treatment and monitor closely for respiratory failure.

COVID-19 Pneumonia

Recognizing Cues (Signs & Symptoms)

Disease Process/Pathophysiology/Risk Factors

• Fever
• Shortness of breath
• Dry cough
• Loss of taste and smell
• Bilateral crackles in lungs

• COVID-19 Pneumonia: Inflammatory lung response caused by SARS-CoV-2 (Gattinoni et al., 2021).
• Acute Respiratory Distress Syndrome (ARDS): Severe cases leading to respiratory failure (Gattinoni et al., 2021).
• Cytokine Storm: Overreaction of the immune system causing severe inflammation.
• Hypoxia: Reduced oxygen levels due to compromised lung function.
• Chronic Conditions: Hypertension, Diabetes increasing risk of severe illness.

Analyzing Cues

Prioritizing Hypotheses

• Fever and Dry Cough: Suggest viral infection, consistent with COVID-19.
• Shortness of Breath and Low Oxygen Saturation: Indicate possible pneumonia or ARDS.
• Crackles in Lungs: Support diagnosis of pneumonia.
• Loss of Taste/Smell: Specific to COVID-19, reinforcing the diagnosis.
• Worsening Symptoms: Point to progression of disease.

• COVID-19 Pneumonia: Primary condition, requires immediate management.
• Hypoxia: Due to impaired gas exchange, priority is given to oxygen therapy.
• Acute Respiratory Failure: Most serious, needs prevention and early detection.

Generate Solutions/Outcomes/Interventions

SMART Planning

Taking Action – (How To)

• The patient will achieve an oxygen saturation level of ≥ 92% within the next 24 hours.
• The patient will maintain a body temperature below 100°F within 12 hours t
• The patient will report a reduction in the severity of shortness of breath and dry cough within 48 hours
• The patient will demonstrate an understanding of COVID-19 isolation measures and symptoms of worsening conditions by the time of discharge

• Administer oxygen via nasal cannula at 4 L/min (Takeshita et al., 2020).
• Administer Remdesivir 200 mg on day 1, followed by daily IV maintenance doses of 100 mg for 5–9 days.
• Administer corticosteroids like Dexamethasone 6 mg once daily for up to 10 days, ^three intravenously (Bahsoun et al., 2023).
• Monitor Vital Signs: Regular checks for signs of deterioration.
• Educate and Reassure the Patient: Provide information on treatment plan and care.

Evaluating Outcomes

• Improved Oxygenation: Goal met, Oxygen saturation > 95%.
• Symptom Relief: Goal met. The patient reported reduced fever and less shortness of breath.
• Stabilized Vital Signs: Goal met, Normalized respiratory and heart rates.
• Effective Management of Chronic Conditions: Goal met: Stable blood pressure (110/70 mmHg)